C-MER MEDICAL (03309) announced its full-year financial results for the fiscal period ending December 31, 2025. The group reported revenue of HK$1.947 billion, representing a year-on-year increase of 1.8%. Shareholders’ attributable profit was HK$100 million, marking a turnaround from a loss in the previous year. Earnings per share stood at HK8.33 cents, and a final dividend of HK2 cents per share was declared.